Published in Ann Oncol on May 02, 2008
Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res (2011) 2.10
The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1). Br J Cancer (2010) 1.06
Current chemotherapeutic management of patients with gestational trophoblastic neoplasia. Chemother Res Pract (2011) 1.06
Case report: malignant teratoma of the uterine corpus. BMC Cancer (2009) 0.97
Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009. Br J Cancer (2012) 0.92
Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease. Curr Obstet Gynecol Rep (2014) 0.80
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for choriocarcinoma: A case report and literature review. Mol Clin Oncol (2016) 0.75
The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia. J Cancer Res Clin Oncol (2012) 0.75
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord (2006) 3.55
Infection and sudden unexpected death in infancy: a systematic retrospective case review. Lancet (2008) 3.44
Conversion of logarithmic channel numbers into relative linear fluorescence intensity. Cytometry (1988) 2.96
Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr Serv (1996) 2.52
Long-term therapy of chronic hepatitis B with lamivudine. Hepatology (2000) 2.49
The earliest electrocardiographic evidence of myocardial infarction. Br Heart J (1970) 2.37
Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord (2006) 2.28
Long-term therapy of chronic delta hepatitis with peginterferon alfa. Aliment Pharmacol Ther (2014) 2.19
Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer (1993) 2.18
Choriocarcinoma and partial hydatidiform moles. Lancet (2000) 2.15
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol (2002) 2.06
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med (2008) 2.03
Down's syndrome screening in the UK. Lancet (1996) 2.02
Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol (1979) 2.02
Electrocardiogram of pure left ventricular hypertrophy and its differentiation from lateral ischaemia. Br Heart J (1981) 2.02
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol (1997) 2.00
Third consensus on medical treatment of metastatic breast cancer. Ann Oncol (2009) 1.96
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet (1991) 1.95
Challenges to implementation of the new Coroners' (Amendment) Rules 2005: experience from a tertiary paediatric pathology centre. Med Sci Law (2007) 1.92
Muscular equivalent of the lower esophageal sphincter. Gastroenterology (1979) 1.83
[Driving tests to determine the influence of alcohol, tranquilizers and hypnotics on driing capability]. Dtsch Med Wochenschr (1969) 1.81
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites. Lancet (2009) 1.81
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A (1998) 1.81
Further advances in the management of malignant teratomas of the testis and other sites. Lancet (1983) 1.80
Gestational trophoblastic disease: current management of hydatidiform mole. BMJ (2008) 1.80
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Predictors of duodenal ulcer healing and relapse. Gastroenterology (1981) 1.78
Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab (1987) 1.78
The role of post-mortem investigations in determining the cause of sudden unexpected death in infancy. Arch Dis Child (2008) 1.77
[Traffic, tranquilizing agents and alcohol]. Dtsch Med Wochenschr (1967) 1.77
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med (2012) 1.76
Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res (1998) 1.70
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol (1997) 1.68
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol (1992) 1.67
Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer (2000) 1.66
Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol (1995) 1.66
The use of toxic equivalency factors in assessing occupational and environmental health risk associated with exposure to airborne mixtures of polycyclic aromatic hydrocarbons (PAHs). Chemosphere (1996) 1.63
The diastolic dilemma. Br Med J (1976) 1.63
Capillary apposition and density in the diagnosis of alveolar capillary dysplasia. Histopathology (2008) 1.62
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol (1995) 1.61
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br J Cancer (1993) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol (1996) 1.54
Carboplatin or cisplatin? Lancet (1988) 1.53
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984). Br J Obstet Gynaecol (1986) 1.53
Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol (2006) 1.53
Endoscopic surgery in weightlessness: the investigation of basic principles for surgery in space. Surg Endosc (2001) 1.53
Problems of an electrocardiogram reporting service. Scott Med J (1969) 1.52
Longitudinal threshold changes in older men with audiometric notches. Hear Res (2000) 1.51
Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations. Eur J Clin Invest (2003) 1.49
Phase I clinical trial of mitozolomide. Cancer Treat Rep (1985) 1.48
Chemotherapy for ovarian germ cell tumours. Eur J Cancer (1996) 1.48
Current optimum management of anaplastic germ cell tumours of the testis and other sites. Br J Urol (1986) 1.48
Trichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management. J Matern Fetal Neonatal Med (2002) 1.46
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat (2000) 1.45
Presence of herpes simplex DNA in surgical tissue from human epileptic seizure foci detected by polymerase chain reaction: preliminary study. Arch Neurol (1997) 1.45
Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction. Am J Obstet Gynecol (1993) 1.45
A 28-year-old woman with a pulmonary embolus. Lancet (1998) 1.44
10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology (1998) 1.44
Lamivudine for chronic delta hepatitis. Hepatology (1999) 1.44
Absent/reduced glucose transporter-1 protein expression in infantile subglottic haemangiomas. Br J Dermatol (2006) 1.43
An electrocardiogram reporting service: its role and its risks. Br Heart J (1969) 1.42
A policy for hypertension. Br Heart J (1975) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer (2012) 1.41
Chemotherapy of advanced malignant teratomas. Br J Cancer (1980) 1.40
Value and limitations of electrocardiogram in diagnosis of slight and subacute coronary attacks. Br Med J (1968) 1.40
Reducing incidence of headache after lumbar puncture and intrathecal cytotoxics. Lancet (1999) 1.40
POMB/ACE chemotherapy for mediastinal germ cell tumours. Eur J Cancer (1997) 1.40
Problems of interpretation of serum concentrations of alpha-foetoprotein (AFP) in patients receiving cytotoxic chemotherapy for malignant germ cell tumours. Br J Cancer (1983) 1.40
[Obstruction ileus caused by mushrooms]. Schweiz Med Wochenschr (1989) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39
Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumours. Ann Oncol (1992) 1.38
3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity. Br J Cancer (1996) 1.38
Venous malformation associated nerve profiles and pain: an immunohistochemical study. J Plast Reconstr Aesthet Surg (2010) 1.38
Second consensus on medical treatment of metastatic breast cancer. Ann Oncol (2006) 1.37
Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.37
Ultrasound screening for anencephaly at 10-14 weeks of gestation. Ultrasound Obstet Gynecol (1997) 1.37
The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care (1997) 1.37
Earliest symptoms of coronary heart disease and their recognition. Br Med J (1972) 1.35
The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol (1989) 1.35
Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res (1997) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer (2007) 1.33
In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs (1997) 1.32
Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG (2003) 1.32
Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients. Br J Cancer (1979) 1.32
Clinical significance of minor ST-T depression in resting electrocardiogram. Br Heart J (1972) 1.31
Presentation and management of choriocarcinoma after nonmolar pregnancy. Br J Obstet Gynaecol (1995) 1.31